Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 13, 2018Antimicrobial Resistance and Infection ControlOpen Access

The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model

View Full Paper
Ask AI
Bookmark
Share

Authors

MMMichal MeirTechnion – Israel Institute of TechnologyPBPablo BifaniAgency for Science, Technology and ResearchDBDaniel BarkanHebrew University of Jerusalem

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Meir et al. (2018) studied this question.

synapsesocial.com/papers/6a95111cdef62415d69e63c3https://doi.org/10.1186/s13756-018-0448-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1β-Lactamase inhibition by avibactam in Mycobacterium abscessus2014 · 173 citations
  2. 2Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment2018 · 61 citations
  3. 3Lung transplant outcomes in cystic fibrosis patients with pre‐operative M ycobacterium abscessus respiratory infections2013 · 108 citations
  4. 4An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases2007 · 6,198 citations
  5. 5Nontuberculous Mycobacteria: I: Multicenter Prevalence Study in Cystic Fibrosis2003 · 626 citations